Guangdong and Shenzhen Key Laboratory of Reproductive Medicine and Genetics, The Center of Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
Mol Genet Genomic Med. 2022 Sep;10(9):e2021. doi: 10.1002/mgg3.2021. Epub 2022 Jul 25.
To expand the mutation spectrum of patients with familial exudative vitreoretinopathy (FEVR) disease.
74 probands (53 families and 21 sporadic probands) with familial exudative vitreoretinopathy (FEVR) disease and their available family members (n = 188) were recruited for sequencing.
Panel-based targeted screening was performed on all subjects. Before sanger sequencing, variants of LRP5, NDP, FZD4, TSPAN12, ZNF408, KIF11, RCBTB1, JAG1, and CTNNA1 genes were verified by a series of bioinformatics tools and genotype-phenotype co-segregation analysis.
40.54% (30/74) of the probands were sighted to possess at least one etiological mutation of the nine FEVR-causative genes. The etiological mutation detection rate was 37.74% (20/53) in family-attainable probands while 47.62% (10/21) in sporadic cases. The diagnosis rate of patients in the early-onset subgroup (≤5 years old, 45.4%) is higher than that of the children or adolescence-onset subgroup (6-16 years old, 42.1%) and the late-onset subgroup (≥17 years old, 39.4%). A total of 36 etiological mutations were identified in this study, comprising 26 novel mutations and 10 reported mutations. LRP5 was the most prevalent mutant gene among the 36 mutation types with a percentage of 41.67% (15/36). Followed by FZD4 (10/36, 27.78%), TSPAN12 (5/36, 13.89%), NDP (4/36, 11.11%), KIF11 (1/36, 2.78%), and RCBTB1 (1/36, 2.78%). Among these mutations, 63.89% (23/36) were missense mutations, 25.00% (9/36) were frameshift mutations, 5.56% (2/36) were splicing mutations, 5.56% (2/36) were nonsense mutations. Moreover, the clinical pathogenicity of these variants was defined according to American College of Medical Genetics (ACMG) and genomics guidelines: 41.67% (15/36) were likely pathogenic variants, 27.78% (10/36) pathogenic variants, 30.55% (11/36) variants of uncertain significance. No etiological mutations discovered in the ZNF408, JAG1, and CTNNA1 genes in this FEVR cohort.
We systematically screened nine FEVR disease-associated genes in a cohort of 74 Chinese probands with FEVR disease. With a detection rate of 40.54%, 36 etiological mutations of six genes were authenticated in 30 probands, including 26 novel mutations and 10 reported mutations. The most prevalent mutated gene is LRP5, followed by FZD4, TSPAN12, NDP, KIF11, and RCBTB1. In total, a de novo mutation was confirmed. Our study significantly clarified the mutation spectrum of variants bounded up to FEVR disease.
扩展家族性渗出性玻璃体视网膜病变(FEVR)患者的突变谱。
74 名(53 个家系和 21 名散发患者)FEVR 患者及其可利用的家族成员(n=188)参与了此次测序研究。
对所有患者进行基于面板的靶向筛选。在进行 Sanger 测序之前,使用一系列生物信息学工具和基因型-表型共分离分析对 LRP5、NDP、FZD4、TSPAN12、ZNF408、KIF11、RCBTB1、JAG1 和 CTNNA1 基因的变异进行验证。
74 名患者中,40.54%(30/74)至少有一种九种 FEVR 致病基因的病因突变。家系中可检测到病因突变的患者检出率为 37.74%(20/53),而散发患者为 47.62%(10/21)。在早发型亚组(≤5 岁,45.4%)的患者诊断率高于儿童或青少年发病亚组(6-16 岁,42.1%)和晚发型亚组(≥17 岁,39.4%)。本研究共发现 36 种病因突变,包括 26 种新突变和 10 种已报道的突变。在 36 种突变类型中,LRP5 是最常见的突变基因,占 41.67%(15/36)。其次是 FZD4(10/36,27.78%)、TSPAN12(5/36,13.89%)、NDP(4/36,11.11%)、KIF11(1/36,2.78%)和 RCBTB1(1/36,2.78%)。这些突变中,63.89%(23/36)为错义突变,25.00%(9/36)为移码突变,5.56%(2/36)为剪接突变,5.56%(2/36)为无义突变。此外,根据美国医学遗传学学院(ACMG)和基因组学指南对这些变异的临床致病性进行了定义:41.67%(15/36)为可能致病性变异,27.78%(10/36)为致病性变异,30.55%(11/36)为意义不明的变异。在本 FEVR 队列中未发现 ZNF408、JAG1 和 CTNNA1 基因的病因突变。
我们系统地筛查了 74 名 FEVR 患者的九种 FEVR 相关基因。检出率为 40.54%,在 30 名患者中证实了 6 个基因的 36 个病因突变,包括 26 个新突变和 10 个已报道的突变。最常见的突变基因为 LRP5,其次是 FZD4、TSPAN12、NDP、KIF11 和 RCBTB1。总共证实了一个新生突变。我们的研究显著阐明了与 FEVR 相关的变异突变谱。